세포 증식 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of cell expansion Market

The global cell expansion market size was valued at USD 22.14 billion in 2025 and is projected to grow from USD 24.82 billion in 2026 to USD 54.04 billion by 2034, exhibiting a CAGR of 10.22% during the forecast period. North America dominated the global cell expansion market with a 51.81% market share in 2025. The market is expanding due to the increasing development of cell and gene therapies, regenerative medicine, tissue engineering, drug discovery, and biopharmaceutical manufacturing.

Cell expansion involves the controlled growth and multiplication of living cells under laboratory conditions for therapeutic, research, and industrial applications. Increasing investments in advanced cell-based therapies and the development of automated cell culture technologies are supporting market growth. In June 2025, Celltrio secured USD 5.0 million in investment to advance automation solutions for cell culturing and cell and gene therapy applications. Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, and other companies are strengthening their portfolios through product development and strategic initiatives.

CELL EXPANSION MARKET KEY TAKEAWAYS

Market Size & Forecast: The market was valued at USD 22.14 billion in 2025, is projected to reach USD 24.82 billion in 2026, and is expected to reach USD 54.04 billion by 2034. The market is expected to grow at a 10.22% CAGR from 2026-2034.

Market Share: North America accounted for 51.81% in 2025. Automated and closed systems are expected to grow at a 13.63% CAGR, while immune cells are projected to grow at a 13.71% CAGR.

Key Regional Highlights: North America reached USD 11.47 billion in 2025, while Europe is projected to reach USD 6.40 billion in 2026. Asia Pacific reached USD 3.52 billion in 2025.

MARKET DYNAMICS

MARKET DRIVERS: Rising Prevalence of Chronic Diseases and Growing Adoption of Cell & Gene Therapies

The rising prevalence of cancer, cardiovascular disorders, and genetic diseases is increasing demand for innovative cell-based treatments. Cell expansion is essential for producing sufficient quantities of cells for therapeutic applications. Growing investments in cell and gene therapies and regenerative medicine are therefore supporting market expansion.

MARKET RESTRAINTS: High Cost of GMP-Grade Cell Expansion

The high cost of GMP-grade cell expansion remains a major restraint. Specialized facilities, advanced equipment, quality controls, and regulatory requirements increase production costs. These expenses can limit accessibility for smaller biotechnology companies and research organizations.

MARKET OPPORTUNITIES: Emergence of Allogenic Cell Therapies

The growing development of allogenic cell therapies is creating opportunities for scalable cell manufacturing. Unlike autologous approaches, allogenic therapies use donor cells and can support the development of off-the-shelf treatments. Increasing investment in allogenic manufacturing platforms is expected to create further demand for cell expansion technologies.

MARKET CHALLENGES: Limited Availability of Skilled Personnel

Cell expansion requires specialized laboratory knowledge and technical expertise. A shortage of trained professionals can create difficulties in operating advanced systems and scaling cell-based research and manufacturing activities.

CELL EXPANSION MARKET TRENDS

Integration of AI in Instruments

The integration of artificial intelligence into cell expansion instruments is emerging as an important trend. AI-enabled systems can improve cell handling, imaging, monitoring, automation, and process optimization. Increasing adoption of digital technologies is supporting more accurate and efficient cell research and manufacturing.

CELL EXPANSION MARKET SEGMENTATION ANALYSIS

By Product Type

The market is segmented into instruments and equipment, consumables, and software and services. Consumables dominated the market in 2025, supported by recurring demand for media, sera, reagents, growth factors, microcarriers, and single-use bioprocessing materials. The instruments and equipment segment is expected to grow at a 8.82% CAGR.

By Technology

The market includes adherent cell expansion technologies, suspension cell expansion technologies, automated and closed systems, and others. Adherent cell expansion technologies held a 41.9% share in 2025, supported by applications in stem cell research and regenerative medicine. Automated and closed systems are expected to grow at a 13.63% CAGR.

By Cell Type

The market includes stem cells, immune cells, differentiated cells, and others. Stem cells dominated with a 36.8% share in 2025, driven by increasing development of stem cell-based therapies. The immune cells segment is expected to grow at a 13.71% CAGR.

By Application

The market is segmented into cell therapy and regenerative medicine, biopharmaceutical production, drug discovery and development, and others. Biopharmaceutical production held a 41.9% share in 2025. The cell therapy and regenerative medicine segment is projected to grow at a 12.58% CAGR.

By End User

Pharmaceutical and biotechnology companies dominated the market with a 45.2% share in 2025. Increasing drug discovery, research investments, and cell-based therapy development are supporting demand. Academic and research institutes are expected to grow at a 7.51% CAGR.

CELL EXPANSION MARKET REGIONAL OUTLOOK

NORTH AMERICA

North America remained the leading regional market, reaching USD 11.47 billion in 2025. The U.S. market reached USD 10.91 billion in 2025, supported by advanced research infrastructure, cell therapy investments, and the presence of major market participants.

EUROPE

Europe is projected to record a 10.00% CAGR and reach USD 6.40 billion in 2026. The U.K., Germany, and France recorded USD 1.25 billion, USD 1.16 billion, and USD 0.91 billion, respectively, in 2025.

ASIA PACIFIC

Asia Pacific reached USD 3.52 billion in 2025, making it the third-largest regional market. India and China recorded USD 0.62 billion and USD 0.64 billion, respectively, in 2025. Japan remains an important market due to increasing adoption of regenerative medicine and advanced cell-based therapies.

LATIN AMERICA

Latin America recorded USD 0.89 billion in 2025. Increasing expansion by market participants and growing interest in automated cell and gene therapy manufacturing are supporting regional development.

MIDDLE EAST & AFRICA

The Middle East & Africa market is expected to experience moderate growth. The GCC market reached USD 0.26 billion in 2025, supported by increasing healthcare and biotechnology investments.

COMPETITIVE LANDSCAPE

Key Industry Players: Expansion of Product Offerings and Research Activities

The global cell expansion market is fragmented, with numerous companies operating across different product and technology categories. Major companies include Thermo Fisher Scientific Inc., Danaher Corporation, Sartorius AG, Merck KGaA, Lonza Group, Corning Incorporated, BD, Terumo Corporation, Miltenyi Biotec, and Eppendorf SE.

KEY INDUSTRY DEVELOPMENTS

September 2025: Sartorius AG expanded its manufacturing facility in Illkirch, France, supporting the production of transfection reagents for cell and gene therapies.

August 2025: Danaher Corporation's Cytiva collaborated with Culture Biosciences to integrate cloud-connected bioreactor technology for digital bioprocessing.

March 2025: Cytiva expanded the Xcellerex X-platform portfolio with 500-L and 2,000-L bioreactors for advanced therapeutic manufacturing.

October 2024: Terumo Corporation expanded its presence in Latin America to support automated manufacturing solutions for cell and gene therapy companies.

October 2023: Terumo Corporation and BioCentriq collaborated on automated cell and gene therapy platforms for CAR-T cell development.

REPORT COVERAGE

The global cell expansion market report covers market size and forecast for 2025, 2026, and 2034, along with segmentation by product type, technology, cell type, application, end user, and geography. The report includes market dynamics, trends, opportunities, challenges, technological advancements, product launches, strategic collaborations, and competitive developments.

CONCLUSION

The global cell expansion market is projected to increase from USD 22.14 billion in 2025 to USD 24.82 billion in 2026 and reach USD 54.04 billion by 2034. Rising adoption of cell and gene therapies, increasing demand for regenerative medicine, expansion of biopharmaceutical manufacturing, and development of automated and closed cell expansion systems are supporting market growth. North America remains the leading regional market, while Europe and Asia Pacific are expanding through investments in cell-based research, advanced therapies, and biomanufacturing technologies.

Segmentation By Product Type, Technology, Cell Type, Application, End User, and Region

By Product Type

• Instruments & Equipment
• Consumables
• Software & Services

By Technology

• Adherent Cell Expansion Technologies
• Suspension Cell Expansion Technologies
• Automated & Closed Systems
• Others

By Cell Type

• Stem Cells
• Immune Cells
• Differentiated Cells
• Others

By Application

• Cell Therapy & Regenerative Medicine
• Biopharmaceutical Production
• Drug Discovery & Development
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Cell Therapy & Regenerative Medicine Centers
• Others

By Geography

• North America (By Product Type, Technology, Cell Type, Application, End User, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Technology, Cell Type, Application, End User, and Country/Sub-region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Overview: Technological Advancements In Cell Expansion
• 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, among others.)
• 4.3. New Product Launches

5. Global Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Instruments & Equipment
  • 5.1.2. Consumables
  • 5.1.3. Software & Services
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Adherent Cell Expansion Technologies
  • 5.2.2. Suspension Cell Expansion Technologies
  • 5.2.3. Automated & Closed Systems
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Cell Type
  • 5.3.1. Stem Cells
  • 5.3.2. Immune Cells
  • 5.3.3. Differentiated Cells
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Cell Therapy & Regenerative Medicine
  • 5.4.2. Biopharmaceutical Production
  • 5.4.3. Drug Discovery & Development
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By End User
  • 5.5.1. Pharmaceutical & Biotechnology Companies
  • 5.5.2. Academic & Research Institutes
  • 5.5.3. Cell Therapy & Regenerative Medicine Centers
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Instruments & Equipment
  • 6.1.2. Consumables
  • 6.1.3. Software & Services
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Adherent Cell Expansion Technologies
  • 6.2.2. Suspension Cell Expansion Technologies
  • 6.2.3. Automated & Closed Systems
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Cell Type
  • 6.3.1. Stem Cells
  • 6.3.2. Immune Cells
  • 6.3.3. Differentiated Cells
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Cell Therapy & Regenerative Medicine
  • 6.4.2. Biopharmaceutical Production
  • 6.4.3. Drug Discovery & Development
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By End User
  • 6.5.1. Pharmaceutical & Biotechnology Companies
  • 6.5.2. Academic & Research Institutes
  • 6.5.3. Cell Therapy & Regenerative Medicine Centers
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Instruments & Equipment
  • 7.1.2. Consumables
  • 7.1.3. Software & Services
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Adherent Cell Expansion Technologies
  • 7.2.2. Suspension Cell Expansion Technologies
  • 7.2.3. Automated & Closed Systems
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Cell Type
  • 7.3.1. Stem Cells
  • 7.3.2. Immune Cells
  • 7.3.3. Differentiated Cells
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Cell Therapy & Regenerative Medicine
  • 7.4.2. Biopharmaceutical Production
  • 7.4.3. Drug Discovery & Development
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By End User
  • 7.5.1. Pharmaceutical & Biotechnology Companies
  • 7.5.2. Academic & Research Institutes
  • 7.5.3. Cell Therapy & Regenerative Medicine Centers
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.6.1. U.K.
  • 7.6.2. Germany
  • 7.6.3. France
  • 7.6.4. Italy
  • 7.6.5. Spain
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia Pacific Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Instruments & Equipment
  • 8.1.2. Consumables
  • 8.1.3. Software & Services
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Adherent Cell Expansion Technologies
  • 8.2.2. Suspension Cell Expansion Technologies
  • 8.2.3. Automated & Closed Systems
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Cell Type
  • 8.3.1. Stem Cells
  • 8.3.2. Immune Cells
  • 8.3.3. Differentiated Cells
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Cell Therapy & Regenerative Medicine
  • 8.4.2. Biopharmaceutical Production
  • 8.4.3. Drug Discovery & Development
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By End User
  • 8.5.1. Pharmaceutical & Biotechnology Companies
  • 8.5.2. Academic & Research Institutes
  • 8.5.3. Cell Therapy & Regenerative Medicine Centers
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.6.1. China
  • 8.6.2. Japan
  • 8.6.3. India
  • 8.6.4. Southeast Asia
  • 8.6.5. Australia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Instruments & Equipment
  • 9.1.2. Consumables
  • 9.1.3. Software & Services
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Adherent Cell Expansion Technologies
  • 9.2.2. Suspension Cell Expansion Technologies
  • 9.2.3. Automated & Closed Systems
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Cell Type
  • 9.3.1. Stem Cells
  • 9.3.2. Immune Cells
  • 9.3.3. Differentiated Cells
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Cell Therapy & Regenerative Medicine
  • 9.4.2. Biopharmaceutical Production
  • 9.4.3. Drug Discovery & Development
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By End User
  • 9.5.1. Pharmaceutical & Biotechnology Companies
  • 9.5.2. Academic & Research Institutes
  • 9.5.3. Cell Therapy & Regenerative Medicine Centers
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Cell Expansion Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Instruments & Equipment
  • 10.1.2. Consumables
  • 10.1.3. Software & Services
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Adherent Cell Expansion Technologies
  • 10.2.2. Suspension Cell Expansion Technologies
  • 10.2.3. Automated & Closed Systems
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Cell Type
  • 10.3.1. Stem Cells
  • 10.3.2. Immune Cells
  • 10.3.3. Differentiated Cells
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Application
  • 10.4.1. Cell Therapy & Regenerative Medicine
  • 10.4.2. Biopharmaceutical Production
  • 10.4.3. Drug Discovery & Development
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By End User
  • 10.5.1. Pharmaceutical & Biotechnology Companies
  • 10.5.2. Academic & Research Institutes
  • 10.5.3. Cell Therapy & Regenerative Medicine Centers
• 10.6. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.6.1. GCC
  • 10.6.2. South Africa
  • 10.6.3. Rest of the Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Thermo Fisher Scientific Inc.
  • 11.2.2. Danaher Corporation
  • 11.2.3. Sartorius AG
  • 11.2.4. Merck KGaA
  • 11.2.5. Lonza Group
  • 11.2.6. Corning Incorporated
  • 11.2.7. BD
  • 11.2.8. Terumo Corporation
  • 11.2.9. Miltenyi Biotec
  • 11.2.10. Eppendorf SE